Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Mature US and European coronary artery bypass graft device markets will Shrink through 2021

July 11, 2013 8:00 am | by PR Newswire | News | Comments

According to Millennium Research Group, the global authority on medical technology market intelligence, declines in isolated coronary artery bypass graft procedures in the United States and Europe will primarily be attributed to the increasing use of percutaneous coronary intervention, which is less invasive and offers shorter recovery times.

Care Interrupted—Top Five Vulnerabilities in Medical Devices

July 10, 2013 3:17 pm | by Matt Neely, Director of Strategic Initiatives, SecureState | Blogs | Comments

Putting medical devices on the network provides a large number of benefits, such as supporting telemedicine and the easy transfer of test results to electronic medical records (EMR) systems. However, putting these devices on a network also introduces a number of risks.

CryoLife wins pre-market approval for laser fiber optic delivery handset

July 10, 2013 3:00 pm | by Mass Device | News | Comments

Vascular surgical device maker CryoLife announced a regulatory green light today with the FDA's pre-market approval of its Sologrip laser fiber optic delivery system. Sologrip is a disposable handset designed to be used during surgery to support a relatively new procedure called transmyocardial revascularization approved by the FDA to treat difficult heart conditions.

Advertisement

Method to Improve Blood Supply to Engineered Replacement Tissues

July 10, 2013 9:38 am | by Mary Ann Liebert, Inc./Genetic Engineering News | News | Comments

Next-generation hydrogels can form synthetic scaffolds to support the formation of replacement tissues and organs in the emerging area of regenerative medicine. Embedding peptides into the hydrogels stimulates the growth of essential microvascular networks to ensure a good blood supply.

Bioengineers Use Adhesion to Combine Silicones and Organic Materials

July 10, 2013 9:34 am | by The Institute for Genomic Biology | News | Comments

In a study reported in the July 1, 2013 Angewandte Chemie, a group of University of Illinois bioengineers have found a way to strongly adhere hydrogels to hydrophobic silicone substrates, an innovation that provides a valuable new tool for microscale biotechnology.

Aptus Exceeds 250 Patients in ANCHOR Post-Market Registry

July 10, 2013 8:15 am | by Business Wire | News | Comments

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that its ANCHOR post-market registry enrollment has surpassed its key milestone of 250 patients.   

LeMaitre Vascular Acquires Clinical Instruments

July 9, 2013 2:45 pm | by Globe Newswire | News | Comments

LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that on July 5, 2013 it acquired the assets of Clinical Instruments International, Inc. for $1.1mm, or 1.7X 2012 sales. Clinical Instruments is based in Southbridge, MA and manufactures carotid shunts and embolectomy catheters.

FDA wants to downgrade blood access devices

July 8, 2013 10:57 am | by Mass Device | News | Comments

The FDA recommended bumping blood access devices down from Class III to Class II regulatory status, based on mounting evidence that these implanted tubes, catheters and cannulae belong in a lower-risk category. The federal watchdog agency said there's enough safety and efficacy data to peel off a layer of regulatory oversight.

Advertisement

1st-in-man trial for Dallen Medical's Compressyn band device

July 8, 2013 9:59 am | by Mass Device | News | Comments

Early-stage device company Dallen Medical announced a 1st-in-man study of its Compressyn band, a breast-plate wire closure device designed to help stabilize patients after open heart surgery. After the sternum is cracked during open-heart surgery, patients require specialized wires to hold the cavity together.

Penumbra, Inc. Launches 5MAX™ ACE—the Newest Clot Extraction Device to Treat Acute Ischemic Stroke Patients

July 8, 2013 8:00 am | by Business Wire | News | Comments

Today, Penumbra, Inc. announced the launch and wide availability of the 5MAX™ ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke. “I’ve used every generation of device for clot removal since the early days, including most recently, the stent retriever devices,” said Blaise Baxter, MD, FRCPC, Director of Interventional Services at Erlanger Hospital.

Gandolfini Death Could Have Been Prevented If Hotel Had AED

July 4, 2013 12:55 pm | by PR Newswire | News | Comments

"James Gandolfini absolutely may have survived if hotel personnel had used an AED when they found him," said Dr. Matthew Budoff, an associate professor of medicine at the David Geffen School of Medicine UCLA and a renowned cardiologist, during an interview.

Early-stage MitrAssist touts $1M funding for valve-in-valve device

July 3, 2013 9:59 am | by Mass Device | News | Comments

Early-stage MitrAssist whizzed by it's hoped-for raise of $600,000, landing $1 million from angel and private investors in support of the company's mitral valve implant. MitrAssist, a spin-out of Tredline Group's accelerator program, is developing what it calls a "valve-on-valve" approach to treat mitral regurgitation for patients too elderly or unstable for an invasive open-heart operation.

Home Healthcare Presents Design Challenges

July 2, 2013 11:54 am | by Ryan Striker, P.E., Electrical Engineer, Logic PD | Logic PD, Inc. | Blogs | Comments

To unlock the potential of more frequent therapy, medical devices must move out of the doctor’s office and travel with patients to their homes and offices. But, this great opportunity is not without its challenges. The same patient who stands to reap great benefit from a home medical device may instead endanger themselves by applying the device incorrectly.

Advertisement

Dallen Medical Initiates “First-in-Man” Clinical Study of its Compressyn™ Band Sternal Closure Device

July 2, 2013 8:00 am | by Business Wire | News | Comments

Dallen Medical, an emerging medical device company, announced today that the first three patients have been treated using its proprietary Compressyn™ Band sternal closure device. The first Compressyn device used for stabilization and rigid fixation following open heart procedures was performed by Dr. Joseph Wilson of Eisenhower Medical Center.

The Obstacles to Design Success for Home Care Products

July 1, 2013 4:38 pm | by Garren Walters, Applications Team Leader, Precision Fluidics Division, Parker Hannifin | Parker Hannifin Corporation | Blogs | Comments

As Parker sees it, the three biggest obstacles to [design] success for patient care products, such as oxygen concentrators and ventilators, are portability, battery life, and reliability. To make home care products more portable, Parker has reduced the size of some valves up to 75%.

Implantable Drug Delivery Devices—An Overview

July 1, 2013 4:13 pm | by James Arps, Ph.D., Director, ProMed Pharma LLC | ProMed Molded Products, Inc. | Articles | Comments

As more therapies are able to indicate implantable devices for treatment, incorporating drug delivery into them can be a significant additional benefit. Even when drug delivery is the primary function, implantable devices can be preferable. This article reviews some representative applications that device designers can leverage in developing new products for the implantable drug delivery market.

ZOLL Announces Acquisition of the Assets of CoAxia

July 1, 2013 11:19 am | by Business Wire | News | Comments

ZOLL Medical Corporation has purchased the assets of CoAxia, an early revenue stage medical device company that provides catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia resulting from vasospasm, following subarachnoid hemorrhage.

DNA in Blood May Help Detection of Artery Disease

July 1, 2013 9:41 am | by American Heart Association | News | Comments

DNA fragments in your blood may someday help doctors quickly learn if chest pain means you have narrowed heart arteries, according to a new study published in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology.

Thoratec Acquires DuraHeart® II Ventricular Assist System

July 1, 2013 8:30 am | by PR Newswire | News | Comments

Thoratec has acquired the DuraHeart II ventricular assist system from Terumo Corporation for an upfront cash payment of $13 million and potential future milestone payments, based on regulatory approvals and product sales, of up to $43.5 million. 

Poland - a New Player in Medical Tourism Sector

June 28, 2013 9:00 am | by PR Newswire | News | Comments

Is it possible, that in 2-3 years Brits, Germans, Scandinavians, and Russians will undergo cancer treatment, orthopaedic, or cardiac surgery procedures in Polish medical facilities more often? Treat teeth and get implants in dental clinics; take a cure in Polish sanatoriums?

Boston Scientific To Acquire C.R. Bard Electrophysiology Business

June 28, 2013 8:30 am | by PR Newswire | News | Comments

In a move that would significantly boost its capabilities in the fast-growing market for advanced electrophysiology procedures, Boston Scientific has entered into a definitive agreement to acquire Bard EP, the electrophysiology business of C.R. Bard, for $275 million in cash.

GPS-Like Technology for CPR More Than Doubles Survival from Leading Cause of Death in the US

June 27, 2013 5:22 pm | by Business Wire | News | Comments

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that survival from one of the leading causes of death in the United States, out-of-hospital cardiac arrest, more than doubled from 26% to 56% when paramedics in Mesa, Arizona utilized ZOLL’s CPR feedback technology in combination with scenario-based training.

Pacemaker Family Features Technology for Adapting Pacing to Respiration

June 27, 2013 4:48 pm | by Boston Scientific | News | Comments

Boston Scientific Corporation is launching a new family of pacemakers in Europe. These pacemakers monitor respiration, adjust pacing accordingly, and support insight into the patient’s overall heart failure status. Comprising of the INLIVEN cardiac resynchronization therapy pacemaker...

New Red Blood Cell Simulator Invented At Queen Mary

June 27, 2013 3:58 pm | by Queen Mary, University of London | News | Comments

Engineers from Queen Mary, University of London have developed the most precise computer simulation of how red blood cells might travel around the body to help doctors treat people with serious circulatory problems. Understanding how damaged red blood cells might interact with each other or their neighboring cells could be useful in realizing blood flow in patients who are diabetic or have had surgery to address circulation complications.

The Pulse: Artificial Pancreas Supplies Insulin to Patients

June 27, 2013 11:13 am | by Eric Sorensen, Coordinator of Multimedia Development | Videos | Comments

On this episode of The Pulse, a major step toward an artificial pancreas, detecting disease from just one drop blood, creating mature human cardiac patches from human heart cells, and a smart sock that helps runners improve their technique and prevent injuries.  

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading